| Primary |
| Rhinitis Allergic |
16.0% |
| Nasal Congestion |
13.3% |
| Product Used For Unknown Indication |
10.7% |
| Hypersensitivity |
9.3% |
| Multiple Allergies |
8.0% |
| Hypertension |
5.3% |
| Chronic Obstructive Pulmonary Disease |
4.0% |
| Sinus Disorder |
4.0% |
| Sinusitis |
4.0% |
| Back Pain |
2.7% |
| Convulsion Prophylaxis |
2.7% |
| Dyspnoea |
2.7% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Hypothyroidism |
2.7% |
| Off Label Use |
2.7% |
| Seasonal Allergy |
2.7% |
| Sinus Congestion |
2.7% |
| Apathy |
1.3% |
| Arthritis |
1.3% |
| Blood Cholesterol Increased |
1.3% |
|
| Nasal Discomfort |
33.3% |
| Epistaxis |
9.8% |
| Anosmia |
7.8% |
| Face Injury |
7.8% |
| Drug Ineffective |
5.9% |
| Pharmaceutical Product Complaint |
3.9% |
| Product Contamination |
3.9% |
| Product Substitution Issue |
3.9% |
| Alopecia |
2.0% |
| Application Site Pain |
2.0% |
| Burning Sensation |
2.0% |
| Candidiasis |
2.0% |
| Dry Skin |
2.0% |
| Enlarged Uvula |
2.0% |
| Eye Irritation |
2.0% |
| Insomnia |
2.0% |
| Instillation Site Pain |
2.0% |
| Laceration |
2.0% |
| Mucosal Dryness |
2.0% |
| Nasal Abscess |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
30.4% |
| Diabetes Mellitus |
9.6% |
| Fatigue |
9.6% |
| Asthma |
7.0% |
| Convulsion Prophylaxis |
7.0% |
| Convulsion |
6.1% |
| Apathy |
4.3% |
| Type 2 Diabetes Mellitus |
3.5% |
| Nasal Congestion |
2.6% |
| Sinus Disorder |
2.6% |
| Back Pain |
1.7% |
| Hepatic Enzyme Increased |
1.7% |
| Hypersensitivity |
1.7% |
| Hypertension |
1.7% |
| Oedema |
1.7% |
| Oedema Peripheral |
1.7% |
| Off Label Use |
1.7% |
| Post-traumatic Epilepsy |
1.7% |
| Seasonal Allergy |
1.7% |
| Sinusitis |
1.7% |
|
| Nausea |
36.7% |
| Nasal Discomfort |
10.0% |
| Oral Intake Reduced |
10.0% |
| Balance Disorder |
6.7% |
| Somnolence |
6.7% |
| Alopecia |
3.3% |
| Anosmia |
3.3% |
| Drug Resistance |
3.3% |
| Dry Skin |
3.3% |
| Oedema Peripheral |
3.3% |
| Pharmaceutical Product Complaint |
3.3% |
| Rash Papular |
3.3% |
| Renal Impairment |
3.3% |
| Thrombocytopenia |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.8% |
| Drug Use For Unknown Indication |
12.2% |
| Pain |
8.7% |
| Hypertension |
6.8% |
| Chronic Obstructive Pulmonary Disease |
3.8% |
| Asthma |
3.4% |
| Hypersensitivity |
3.2% |
| Depression |
3.1% |
| Blood Pressure |
3.0% |
| Diabetes Mellitus |
2.9% |
| Gastrooesophageal Reflux Disease |
2.7% |
| Non-small Cell Lung Cancer |
2.5% |
| Anxiety |
2.5% |
| Hiv Infection |
2.5% |
| Insomnia |
2.5% |
| Atrial Fibrillation |
2.3% |
| Back Pain |
2.0% |
| Prophylaxis |
1.8% |
| Constipation |
1.7% |
| Smoking Cessation Therapy |
1.6% |
|
| Nausea |
8.7% |
| Myalgia |
7.5% |
| Weight Increased |
6.8% |
| Tremor |
6.2% |
| Breast Cancer In Situ |
5.6% |
| Ultrasound Scan Abnormal |
5.6% |
| Vomiting |
5.6% |
| Rash |
5.0% |
| Thrombocytopenia |
5.0% |
| Visual Impairment |
5.0% |
| Weight Decreased |
5.0% |
| Cough |
4.3% |
| Dyspnoea |
4.3% |
| White Blood Cell Count Decreased |
4.3% |
| Death |
3.7% |
| Renal Failure |
3.7% |
| Renal Failure Acute |
3.7% |
| Urticaria |
3.7% |
| Headache |
3.1% |
| Sepsis |
3.1% |
|
